CD90 Antikörper (N-Term)
Kurzübersicht für CD90 Antikörper (N-Term) (ABIN388803)
Target
Alle CD90 (THY1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Bindungsspezifität
- AA 36-65, N-Term
- 
                                            Aufreinigung
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- 
                                            Immunogen
- This THY1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 36-65 amino acids from the N-terminal region of human THY1.
- 
                                            Isotyp
- Ig Fraction
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100. IHC-P: 1:10~50. IHC-P: 1:50~100
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- 4 °C,-20 °C
- 
                                            Informationen zur Lagerung
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
- 
                                            Haltbarkeit
- 6 months
 
- 
                                            
- 
    - 
                                            : "The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas."    in: Pathology, research and practice, Vol. 212, Issue 7, pp. 636-42, (2017)         (PubMed).        
 : "Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method." in: PLoS ONE, Vol. 10, Issue 7, pp. e0134727, (2015) (PubMed).
 : "Analogy between sphere forming ability and stemness of human hepatoma cells." in: Oncology reports, Vol. 24, Issue 5, pp. 1147-51, (2011) (PubMed).
 : "High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma." in: Gut, Vol. 59, Issue 7, pp. 953-62, (2010) (PubMed).
 
 
- 
                                            : "The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas."    in: Pathology, research and practice, Vol. 212, Issue 7, pp. 636-42, (2017)         (PubMed).        
- 
    - CD90 (THY1)
- 
                                            Andere Bezeichnung
- THY1
- 
                                            Hintergrund
- THY1 (CD90) antigen is a GPI linked glycoprotein member of the Immunoglobulin superfamily. It is expressed on murine T cells, thymocytes, neural cells, cells of granulocytic lineage, early hematopoietic progenitors, fibroblasts, neurons and Kupffer's cells. Thy1 may play a role in cell to cell or cell to ligand interactions during synaptogenesis and other events in the brain.
- 
                                            Molekulargewicht
- 17935
- 
                                            Gen-ID
- 7070
- 
                                            NCBI Accession
- NP_006279
- 
                                            UniProt
- P04216
- 
                                            Pathways
- Cell-Cell Junction Organization
 Target
- 
                    
 
                                     
                                     
                                    